RxREVU
Latest round
- Series B
Last raised
- Jan 2021
Total raised
- $23M
Investors
- 7
About RxREVU
, trading under the name Arrive Health, operates as a Prescription Decision Support company that develops a prescription intelligence platform designed to manage and measure doctor's prescribing performance. The company has reached 2,000 hospitals in less than two years. In March 2026, Arrive Health merged with DoseSpot to form Interra Health. The company's technology includes SwiftRx Direct, which brings real-time, patient and pharmacy-specific cost information, coverage restrictions, and therapeutic alternatives into native electronic health record (EHR) workflows; SwiftRx Navigator, which combines evidence-based guidelines, therapeutic alternatives, and real-time, patient-specific cost information in an EHR-embedded decision support application; and SwiftRx Insights, which provides behavioral analytics to help organizations reduce care variability, improve patient safety, and manage pharmacy risk. RxREVU delivers custom reporting to analyze actionable insights and tracks the critical metrics around prescribing drugs to patients based on their medical history, drug allergies, and insurance coverage, enabling healthcare professionals to make more informed prescribing decisions. RxRevu partners with providers, payers, and pharmacy benefit managers, and EHR vendors to improve healthcare by providing accurate, patient-specific coverage and cost data at the point-of-care. Its technology solution will help physicians quickly and easily find affordable care options specific to a patient's health and financial needs.
Who invested in RxREVU
7 investors across 2 rounds
See all investors in RxREVU
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about RxREVU
Who invested in RxREVU?
RxREVU has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has RxREVU raised?
RxREVU has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did RxREVU last raise money?
RxREVU's most recent round on record is a Series B, in Jan 2021.
What does RxREVU do?
, trading under the name Arrive Health, operates as a Prescription Decision Support company that develops a prescription intelligence platform designed to manage and measure doctor's prescribing performance.
Where is RxREVU headquartered?
RxREVU is headquartered in Denver, US.
Which VCs invest in companies like RxREVU?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at RxREVU's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series B
Raising like RxREVU? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.